| 000 | 01869 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518075725.0 | ||
| 264 | 0 | _c20200428 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1466-609X | ||
| 024 | 7 |
_a10.1186/s13054-019-2704-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Anbiao | |
| 245 | 0 | 0 |
_aProphylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. _h[electronic resource] |
| 260 |
_bCritical care (London, England) _c12 2019 |
||
| 300 |
_a428 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aCardiac Output, Low _xepidemiology |
| 650 | 0 | 4 |
_aCardiac Surgical Procedures _xadverse effects |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadverse effects |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Defects, Congenital _xsurgery |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRespiration, Artificial |
| 650 | 0 | 4 |
_aSimendan _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCui, Chaomei | |
| 700 | 1 | _aFan, Yiou | |
| 700 | 1 | _aZi, Jie | |
| 700 | 1 | _aZhang, Jie | |
| 700 | 1 | _aWang, Guanglai | |
| 700 | 1 | _aWang, Fang | |
| 700 | 1 | _aWang, Jun | |
| 700 | 1 | _aTan, Qi | |
| 773 | 0 |
_tCritical care (London, England) _gvol. 23 _gno. 1 _gp. 428 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13054-019-2704-2 _zAvailable from publisher's website |
| 999 |
_c30471044 _d30471044 |
||